Jeil Pharm (002620) — Cash Flow Quality Index
Latest as of March 2026:
0.41x
Jeil Pharm (002620) has a Cash Flow Quality Index of 0.41x as of March 2026. Operating cash flow of ₩447.08 Million is below net income of ₩1.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 002620 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.41x
Operating CF / Net Income
Operating Cash Flow
₩447.08 Million
KRW
Net Income
₩1.10 Billion
KRW
Data as of
Mar 2026
Most recent filing
Jeil Pharm Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Jeil Pharm across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Jeil Pharm cash conversion from operations.
Annual Cash Flow Quality Index for Jeil Pharm (2011–2025)
Year-by-year earnings quality comparison for Jeil Pharm.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | ₩390.26 Million | ₩14.64 Billion | ▲ +101.3% |
| 2020 | -2.07x | ₩-23.67 Billion | ₩11.43 Billion | ▼ -326.5% |
| 2018 | -0.49x | ₩-3.43 Billion | ₩7.07 Billion | ▼ -4365.5% |
| 2017 | 0.01x | ₩5.92 Billion | ₩520.35 Billion | ▼ -99.2% |
| 2016 | 1.44x | ₩11.36 Billion | ₩7.89 Billion | ▲ +412.1% |
| 2015 | 0.28x | ₩2.74 Billion | ₩9.76 Billion | ▲ +179.6% |
| 2012 | -0.35x | ₩-3.94 Billion | ₩11.17 Billion | ▼ -140.4% |
| 2011 | 0.87x | ₩23.63 Billion | ₩27.01 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.